Thanks SF. In my research it is becoming clear that the MM products for epilepsy are not a one size fits all on both counts. That is the mm products are unique formulations which work on specific epilepsy conditions. GW product was targeting two very rare forms yet gets promoted as epilepsy drug as if it deals with all forms. Tilrays while it seems to be a small test samples sounds as if it is for a broader range so could well be direct competition...
- Forums
- ASX - By Stock
- RGT
- Cannepil
RGT
argent biopharma limited
Add to My Watchlist
3.95%
!
7.9¢

Cannepil, page-47
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
7.9¢ |
Change
0.003(3.95%) |
Mkt cap ! $5.702M |
Open | High | Low | Value | Volume |
7.6¢ | 7.9¢ | 7.5¢ | $1.169K | 15.44K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 13157 | 7.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.0¢ | 16105 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 13157 | 0.076 |
2 | 23143 | 0.075 |
1 | 56000 | 0.074 |
5 | 84942 | 0.073 |
1 | 10000 | 0.072 |
Price($) | Vol. | No. |
---|---|---|
0.090 | 16105 | 1 |
0.095 | 74 | 1 |
0.100 | 20000 | 1 |
0.120 | 8340 | 1 |
0.150 | 32000 | 1 |
Last trade - 11.32am 23/07/2025 (20 minute delay) ? |
Featured News
RGT (ASX) Chart |